ARAB PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of ADCI for the last quarter is 222.66 M EGP, and it's 16.43% higher compared to the previous quarter. The net income of Q2 24 is 32.81 M EGP.